On August 15, 2017, the Company's Board of Directors authorized a program (the "Program") to repurchase up to $100 million of the Company’s common stock on or before August 1, 2020. In 2018 and 2019, the Board of Directors increased the share repurchase authorization under the Program to $200 million and $300 million, respectively. On July 3, 2020, the Board of Directors increased the share repurchase authorization under the Company's existing share repurchase program by an additional $100 million to $400 million, and extended its duration through August 1, 2022. The Company has entered into a written trading plan under Rule 10b5-1 of the Exchange Act to facilitate repurchases under the Program. The Program may be suspended or discontinued at any time and is funded using the Company's available cash, cash equivalents and short-term investments. Under the Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the Program depend on market conditions as well as corporate and regulatory considerations.

During the fiscal year ended October 3, 2020, the Company repurchased a total of approximately 2.5 million shares of common stock at a cost of approximately $55.0 million. The share repurchases were recorded in the periods they were delivered and accounted for as treasury stock in the Company’s Consolidated Balance Sheets. The Company records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If the Company reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between acquisition cost and the reissue price, this difference is recorded against retained earnings. As of October 3, 2020, our remaining share repurchase authorization under the Program was approximately $142.1 million.

On August 26, 2020, May 29, 2020, February 20, 2020 and December 12, 2019, the Board of Directors declared a quarterly dividend $0.12 per share of common stock. During the fiscal year ended October 3, 2020, the Company declared dividends of $0.48 per share of common stock. The declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on the Company's financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company's stockholders.


	As of
(in thousands)	October 3, 2020		September 28, 2019
Gain / (loss) from foreign currency translation adjustments	$	10	$	(7,745)
Unrecognized actuarial loss on pension plan, net of tax	(3,088)		(1,598)
Unrealized gain / (loss) on hedging	557		(597)
Accumulated other comprehensive loss	$	(2,521)	$	(9,940)

The Company has stockholder-approved equity-based employee compensation plans (the “Employee Plans”) and director compensation plans (the “Director Plans”) (collectively, the “Equity Plans”). As of October 3, 2020, 3.4 million shares of common stock are available for grant to the Company's employees and directors under the 2017 Equity Plan, including previously registered shares that have been carried forward for issuance under the 2009 Equity Plan.

•Relative TSR Performance Share Units ("Relative TSR PSUs") entitle the employee to receive common shares of the Company on the award vesting date if market performance objectives which measure relative total shareholder return (“TSR”) are attained. Relative TSR is calculated based upon the 90-calendar day average price of the Company's stock as compared to specific peer companies that comprise the GICS (45301020) Semiconductor Index. TSR is measured for the Company and each peer company over a performance period, which is generally three years. Vesting percentages range from 0% to 200% of awards granted. The provisions of the Relative TSR PSUs are reflected in the

grant date fair value of the award; therefore, compensation expense is recognized regardless of whether the market condition is ultimately satisfied. Compensation expense is reversed if the award is forfeited prior to the vesting date.

•In general, stock options and Time-based Restricted Share Units ("Time-based RSUs") awarded to employees vest annually over a three-year period provided the employee remains employed by the Company. The Company follows the non-substantive vesting method for stock options and recognizes compensation expense immediately for awards granted to retirement-eligible employees, or over the period from the grant date to the date retirement eligibility is achieved.

•Special/Growth Performance Share Units (“Special/Growth PSUs”) entitle the employee to receive common shares of the Company on the three-year anniversary of the grant date (if employed by the Company) if revenue growth targets set by the Management Development and Compensation Committee (“MDCC”) of the Board of Directors on the date of grant are met. If revenue growth targets are not met, the Special/Growth PSUs do not vest. Certain Special/Growth PSUs vest based on achievement of strategic goals over a certain time period or periods set by the MDCC. If the strategic goals are not achieved, the Special/Growth PSUs do not vest.

•In general, Performance-based Restricted Stock entitles the employee to receive common shares of the Company on the three-year anniversary of the grant date (if employed by the Company) if return on invested capital and revenue growth targets set by the Management Development and Compensation Committee (“MDCC”) of the Board of Directors on the date of grant are met. If return on invested capital and revenue growth targets are not met, Performance-based Restricted Stock does not vest. Certain PSUs vest based on achievement of strategic goals over a certain time period or periods set by the MDCC. If the strategic goals are not achieved, the PSUs do not vest.

Equity-based compensation expense recognized in the Consolidated Statements of Operations for fiscal 2020, 2019, and 2018 was based upon awards ultimately expected to vest. Following the early adoption in the first quarter of fiscal 2018 of ASU 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, forfeitures have been accounted for when they occur.

The following table reflects total equity-based compensation expense, which includes Relative TSR PSUs, Time-based RSUs, Special/Growth PSUs, Performance-based Restricted Stock and common stock, included in the Consolidated Statements of Operations for fiscal 2020, 2019, and 2018:


	Fiscal
(in thousands)	2020		2019		2018
Cost of sales	$	744	$	632	$	515
Selling, general and administrative	11,071		10,503		8,548
Research and development	3,204		3,197		2,622
Total equity-based compensation expense	$	15,019	$	14,332	$	11,685


	Fiscal
(in thousands)	2020		2019		2018
Relative TSR PSUs	$	3,266	$	4,220	$	3,583
Time-based RSUs	9,519		8,603		7,027

Special/Growth PSUs	1,384		675		295
Common stock	850		834		780
Total equity-based compensation expense	$	15,019	$	14,332	$	11,685


	Number of shares (in thousands)	Unrecognized compensation expense (in thousands)		Average remaining service period (in years)	Weighted average grant date fair value per share
Relative TSR PSUs outstanding as of September 30, 2017	673	$	6,204	1.4
Granted	180				$	29.60
Forfeited or expired	(146)
Vested	(168)
Relative TSR PSUs outstanding as of September 29, 2018	539	$	4,629	1.1
Granted	166				$	23.15
Forfeited or expired	(27)
Vested	(117)
Relative TSR PSUs outstanding as of September 28, 2019	561	$	4,136	0.9
Granted	162				$	28.80
Forfeited or expired	(52)
Vested	(268)
Relative TSR PSUs outstanding as of October 3, 2020	403	$	4,198	1.1


	Number of shares (in thousands)	Unrecognized compensation expense (in thousands)		Average remaining service period (in years)	Weighted average grant date fair value per share
Time-based RSUs outstanding as of September 30, 2017	1,080	$	7,770	1.5
Granted	459				$	22.32
Forfeited or expired	(87)
Vested	(542)
Time-based RSUs outstanding as of September 29, 2018	910	$	9,038	1.4
Granted	521				$	20.95
Forfeited or expired	(42)
Vested	(442)
Time-based RSUs outstanding as of September 28, 2019	947	$	10,555	1.4
Granted	490				$	22.93
Forfeited or expired	(80)
Vested	(569)
Time-based RSUs outstanding as of October 3, 2020	788	$	10,480	1.6


	Number of shares (in thousands)	Unrecognized compensation expense (in thousands)		Average remaining service period (in years)	Weighted average grant date fair value per share
Special/Growth PSUs outstanding as of September 30, 2017	—
Granted	60				$	22.57
Forfeited or expired	(14)
Vested	—
Special/Growth PSUs outstanding as of September 29, 2018	46	$	702	2.1
Granted	55				$	21.07
Forfeited or expired	(4)
Vested	—
Special/Growth PSUs outstanding as of September 28, 2019	97	$	1,128	1.6
Granted	80				$	23.65
Forfeited or expired	(22)
Vested	(4)
Special/Growth PSUs outstanding as of October 3, 2020	151	$	1,252	1.1


	Number of shares (in thousands)	Weighted average exercise price		Average remaining contractual life (in years)	Aggregate intrinsic value (in thousands)
Options outstanding as of September 30, 2017	16	$	8.73

Exercised	(6)	$	8.74		$	73
Forfeited or expired	(8)	$	8.74
Options outstanding as of September 29, 2018	2	$	8.64

Exercised	(2)	$	8.64		$	24
Forfeited or expired	—
Options outstanding as of September 28, 2019	—

Exercised	—				$	—
Forfeited or expired	—	$	—
Options outstanding as of October 3, 2020	—	$	—	—	$	—
Options vested and expected to vest as of October 3, 2020	—	$	—	—	$	—
Options exercisable as of October 3, 2020	—	$	—	—
In the money exercisable options as of October 3, 2020	—				$	—

Intrinsic value of stock options exercised is determined by calculating the difference between the market value of the Company's stock price at the time an option is exercised and the exercise price, multiplied by the number of shares.

The 2017 Equity Plan provides for the grant of common shares to each non-employee director upon initial election to the board and on the first business day of each calendar quarter while serving on the board. The grant to a non-employee director upon initial election to the board is that number of common shares closest in value to, without exceeding, $120,000. The quarterly grant to a non-employee director upon the first business day of each calendar quarter is that number of common shares closest in value to, without exceeding, $37,000.